Sartorius Stedim Biotech Announces Share and Voting Rights Update

Sartorius Stedim Biotech SA, headquartered in Aubagne, France, has released its latest update on share and voting rights. As of July 31, 2026, the company reports a total of 97,330,405 shares making up its issued capital. The total number of theoretical voting rights, which includes treasury shares, stands at 164,770,933. Meanwhile, the total net voting rights are slightly lower at 164,721,373.

This declaration conforms to Article L 233-8-II of the French Code of Commerce and Article 223-6 of the AMF's general regulations. The information is pertinent for investors and regulatory compliance, ensuring transparency in the company's financial structure.